Global Covered Stent Market Size By Type (AAA Stent Grafts, TAA Stent Grafts), By Application (Peripheral Stent Grafts, Aortic Stent Grafts), By Region, And Segment Forecasts, 2023 to 2032

The Global Covered Stent Market was valued at USD X billion in 2023 and is projected to surpass USD X billion by 2031, growing at a CAGR of X% during the forecast period from 2023 to 2031. The market is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and advancements in stent technology. Covered stents, also known as stent grafts, are widely used in treating aneurysms, arterial injuries, and stenotic lesions, providing structural support while preventing vessel leakage.

With the growing burden of coronary artery disease (CAD) and peripheral arterial disease (PAD) worldwide, covered stents have become a crucial component in interventional cardiology. The introduction of biodegradable and drug-eluting covered stents is further enhancing patient outcomes, leading to significant market expansion.

Drivers

1. Rising Incidence of Cardiovascular Diseases (CVDs)

The increasing prevalence of cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and aneurysms, is a key driver for market growth.

The World Health Organization (WHO) states that cardiovascular diseases remain the leading cause of mortality worldwide.

2. Advancements in Stent Technology

The development of drug-eluting covered stents, bioresorbable stents, and next-generation stent coatings is enhancing the efficiency and longevity of stent procedures.

Innovations in nanotechnology and polymer coatings are improving biocompatibility and reducing the risk of restenosis.

3. Increasing Demand for Minimally Invasive Procedures

Growing preference for catheter-based interventions over open surgeries is fueling the demand for covered stents.

Shorter recovery times, lower risks, and improved patient comfort contribute to the adoption of covered stents in medical procedures.

Restraints

1. High Cost of Covered Stent Procedures

The expensive nature of stent grafts and associated medical procedures can be a major challenge, particularly in developing economies with limited healthcare budgets.

Lack of reimbursement policies in some regions can further hinder market growth.

2. Risk of Complications and Device Failures

Covered stents may pose risks such as thrombosis, restenosis, and stent migration.

The need for continuous monitoring and secondary interventions increases healthcare costs and limits patient adoption.

Opportunity

1. Growth in Emerging Markets

Countries such as India, China, and Brazil are witnessing a rise in healthcare expenditure and an increasing number of cardiovascular interventions, presenting lucrative market opportunities.

Government initiatives and expanding healthcare infrastructure are promoting access to stent-based treatments.

2. Integration of AI and Robotics in Stent Deployment

The development of AI-driven diagnostics and robotic-assisted stent placements is revolutionizing precision medicine.

Robotic catheter systems and AI-guided imaging enhance procedural accuracy, reducing human error and improving patient outcomes.

Market by System Type Insights

1. Drug-Eluting Covered Stents

Dominated the market in 2023 and is expected to retain its position due to its superior anti-restenotic properties.

These stents release medication to prevent re-narrowing of arteries, reducing the need for repeat procedures.

2. Self-Expanding Covered Stents

Preferred for peripheral artery disease (PAD) and venous applications due to their ability to conform to vascular structures.

Their flexibility and ease of deployment make them a popular choice in complex vascular conditions.

3. Balloon-Expandable Covered Stents

Commonly used in coronary artery disease (CAD) treatments.

These stents provide rigid structural support, making them suitable for treating high-pressure vascular lesions.

Market by End-Use Insights

1. Hospitals

Hospitals accounted for the largest revenue share in 2023, as they are the primary centers for cardiovascular interventions.

The presence of state-of-the-art catheterization labs and specialized cardiac care units is driving market growth.

2. Ambulatory Surgical Centers (ASCs)

Fastest-growing segment due to the increasing number of outpatient cardiovascular procedures.

Lower costs, faster recovery, and reduced hospital stays make ASCs an attractive option for stent procedures.

3. Specialty Clinics

Growing adoption of minimally invasive treatments in specialty clinics is contributing to market expansion.

These clinics provide personalized cardiovascular care with advanced imaging technologies.

Market by Regional Insights

1. North America

Dominated the market in 2023, accounting for the largest share due to:

High prevalence of cardiovascular diseases.

Strong presence of key market players and advanced healthcare infrastructure.

Favorable reimbursement policies for stent procedures.

2. Europe

Second-largest market, driven by increasing adoption of minimally invasive surgeries and rising demand for drug-eluting stents.

Countries like Germany, France, and the UK are leading contributors to market growth.

3. Asia-Pacific

Fastest-growing region, fueled by:

Expanding healthcare access.

Rising cases of cardiovascular disorders due to changing lifestyles and aging populations.

Increased government funding for medical infrastructure.

4. Latin America & Middle East & Africa (LAMEA)

Growth is driven by improving healthcare facilities and rising awareness of cardiovascular treatments.

Economic constraints and limited reimbursement policies remain key challenges.

Competitive Scenario

Key players in the Global Covered Stent Market include:

Abbott Laboratories

Medtronic plc

Boston Scientific Corporation

Cook Medical

Becton, Dickinson and Company (BD)

Terumo Corporation

Endologix LLC

Bentley InnoMed GmbH

Key Market Developments

Abbott launched a next-generation drug-eluting covered stent in 2023, designed to enhance endothelial healing and minimize restenosis.

Medtronic introduced an AI-assisted stent placement system in 2024, improving procedural accuracy and patient safety.

Boston Scientific expanded its covered stent portfolio in 2025, focusing on biodegradable stent technology to reduce long-term complications.

Scope of Work – Global Covered Stent Market